Has the new sexual desire drug panned out?
During the initial months of availability for flibanserin (Addyi), the first medication for sexual desire disorders, there was not a big demand for the drug. Doctors say this may be due to the fact that the drug has a steep price tag and severe potential side effects, including very low blood pressure, fainting, and nausea. These risks become greater if a woman drinks alcohol or takes birth control pills. There are also strict rules for prescribing and dispensing the drug.
To continue reading this article, you must log in.
Source matters. Subscribe to HarvardHealthOnline+ FREE for 30 days for unlimited access to the site – where all content is reviewed by an HMS physician or faculty expert.
With HHO+ you get these exclusive benefits:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
SPECIAL OFFER! UNLOCK EXPERT ACCESS for 30 days FREE!
Already a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
